Schroder Investment Management Group
BCRX icon

Schroder Investment Management Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Schroder Investment Management Group’s Portfolio BCRX Stock Details BCRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.05M Buy
2025
Q2 		– Sell
2025
Q1 		$4.11M Hold
2024
Q4 		$3.94M Buy
2024
Q3 		$638K Buy
2020
Q1 		– Sell
2019
Q4 		$191K Buy